Synonyms: MEDI3902
Compound class:
Antibody
Comment: Gremubamab (MEDI3902) is a bivalent, bispecific monoclonal antibody [2]. It is under clinical development as a treatment for nosocomial pneumonia caused by Pseudomonas aeruginosa.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
10909 | gremubamab |
Synonyms ![]() |
MEDI3902 |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
MEDI3902 |
IMGT/mAb-DB | 953 |
Other databases | |
CAS Registry No. | 1800381-36-5 (source: Scifinder) |
ChEMBL Ligand | CHEMBL4298031 |
DrugBank Ligand | DB15014 |
GtoPdb PubChem SID | 496703344 |
Search PubMed clinical trials | gremubamab |
Search PubMed titles | gremubamab |
Search PubMed titles/abstracts | gremubamab |